2019 - Tentative Meeting Schedule
- March 10-11, 2019 (cancelled)
- June 9-10, 2019 (cancelled)
- September 8-9, 2019 (deadline for submissions is end of day Wednesday, July 10, 2019)
- December 1-2, 2019 (deadline for submissions is end of day Wednesday, October 2, 2019)
NAPRA typically reviews drug scheduling applications in the order in which they are received at the NDSAC Secretariat along with applicable fees. NAPRA reserves the authority to change the review sequence if it is determined to be in the public interest to do so. Any decision to modify the usual review sequence is determined jointly by the Chair of NDSAC and the Executive Director of NAPRA. Meeting the posted deadline for submission does not, therefore, guarantee that the application will be reviewed at the corresponding NDSAC meeting. There is a limit of two submissions reviewed at any given meeting.